Enzo Biochem, Inc. (ENZ) Misses Q1 Views
Tweet
Share
E-mailGet Alerts ENZ Hot Sheet
Join SI Premium – FREE
Enzo Biochem, Inc. (NYSE: ENZ) reported Q1 EPS of ($0.12), $0.04 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $25.75 million versus the consensus estimate of $27.04 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Jernigan Capital (JCAP) Tops Q2 EPS by 5c
- Marpai, Inc. (MRAI) Misses Q2 EPS by 18c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
